FLT3 and acute myeloid leukemia: The dual Aurora/FLT3 inhibitor CCT137690 (Figure 5) was identified following a medicinal chemistry program starting from an in-house Aurora inhibitor series [74] and was shown to inhibit the growth of FLT3 inhibitor-resistant AML cell lines [73].